Phase I Study and Pilot Efficacy Analysis of Entinostat, a Novel Histone Deacetylase Inhibitor, in Chinese Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer

BACKGROUND: Previous clinical trials have demonstrated that entinostat in combination with exemestane had good tolerability and significant clinical efficacy in patients with advanced hormone receptor positive (HR+) and HER2 negative (HER2−) metastatic breast cancer (MBC) in the USA. However, no cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jiani, Zhang, Qingyuan, Li, Qiao, Mu, Yuxin, Jing, Jing, Li, Huiping, Li, Wei, Wang, Jingfen, Yu, Guohua, Wang, Xian, Ouyang, Quchang, Hao, Jing, Lu, Liang, Zhou, Li, Guan, Jin, Li, Qing, Xu, Binghe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484140/
https://www.ncbi.nlm.nih.gov/pubmed/34196874
http://dx.doi.org/10.1007/s11523-021-00823-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484140/
https://www.ncbi.nlm.nih.gov/pubmed/34196874
http://dx.doi.org/10.1007/s11523-021-00823-4

Ejemplares similares